These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35632009)

  • 1. Tablet Formulations of Polymeric Electrospun Fibers for the Controlled Release of Drugs with pH-Dependent Solubility.
    Friuli V; Pisani S; Conti B; Bruni G; Maggi L
    Polymers (Basel); 2022 May; 14(10):. PubMed ID: 35632009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of lipid and cellulose based matrix former on the release of highly soluble drug from extruded/spheronized, sintered and compacted pellets.
    Maboos M; Yousuf RI; Shoaib MH; Nasiri I; Hussain T; Ahmed HF; Iffat W
    Lipids Health Dis; 2018 Jun; 17(1):136. PubMed ID: 29885655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrospun polycaprolactone nanofibers as a potential oromucosal delivery system for poorly water-soluble drugs.
    Potrč T; Baumgartner S; Roškar R; Planinšek O; Lavrič Z; Kristl J; Kocbek P
    Eur J Pharm Sci; 2015 Jul; 75():101-13. PubMed ID: 25910438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Divisability of diltiazem matrix sustained-release tablets.
    Costa P; Sousa Lobo JM
    Pharm Dev Technol; 2001 Aug; 6(3):343-51. PubMed ID: 11485176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation design and characterization of an elementary osmotic pump tablet of flurbiprofen.
    Patel KN; Mehta TA
    PDA J Pharm Sci Technol; 2014; 68(4):333-46. PubMed ID: 25035256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrospun amorphous solid dispersions of meloxicam: Influence of polymer type and downstream processing to orodispersible dosage forms.
    Casian T; Borbás E; Ilyés K; Démuth B; Farkas A; Rapi Z; Bogdan C; Iurian S; Toma V; Știufiuc R; Farkas B; Balogh A; Marosi G; Tomuță I; Nagy ZK
    Int J Pharm; 2019 Oct; 569():118593. PubMed ID: 31398371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Dissolution Medium pH and Simulated Gastrointestinal Contraction on Drug Release From Nifedipine Extended-Release Tablets.
    Gao Z; Ngo C; Ye W; Rodriguez JD; Keire D; Sun D; Wen H; Jiang W
    J Pharm Sci; 2019 Mar; 108(3):1189-1194. PubMed ID: 30343136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrospun fibers as potential carrier systems for enhanced drug release of perphenazine.
    Bruni G; Maggi L; Tammaro L; Lorenzo RD; Friuli V; D Aniello S; Maietta M; Berbenni V; Milanese C; Girella A; Marini A
    Int J Pharm; 2016 Sep; 511(1):190-197. PubMed ID: 27418562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of xanthan gum based sustained release matrix tablets containing highly water-soluble propranolol HCl.
    Ali A; Iqbal M; Akhtar N; Khan HM; Ullah A; Uddin M; Khan MT
    Acta Pol Pharm; 2013; 70(2):283-9. PubMed ID: 23614284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation of poloxamer-based nanofibers for enhanced dissolution of carvedilol.
    Kajdič S; Vrečer F; Kocbek P
    Eur J Pharm Sci; 2018 May; 117():331-340. PubMed ID: 29514051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of Within-Tablet Dynamics for Extended Release of a Poorly Soluble Basic Drug from Hydrophilic Matrix Tablets Using ATR-FTIR Imaging.
    Zahoor FD; Mader KT; Timmins P; Brown J; Sammon C
    Mol Pharm; 2020 Apr; 17(4):1090-1099. PubMed ID: 32069060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality by Design approach to understand the physicochemical phenomena involved in controlled release of captopril SR matrix tablets.
    Saurí J; Millán D; Suñé-Negre JM; Colom H; Ticó JR; Miñarro M; Pérez-Lozano P; García-Montoya E
    Int J Pharm; 2014 Dec; 477(1-2):431-41. PubMed ID: 25445523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current strategies for sustaining drug release from electrospun nanofibers.
    Chou SF; Carson D; Woodrow KA
    J Control Release; 2015 Dec; 220(Pt B):584-91. PubMed ID: 26363300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testing lyoequivalency for three commercially sustained-release tablets containing diltiazem hydrochloride.
    Maswadeh HA; Al-Hanbali OA; Kanaan RA; Shakya AK; Maraqa A
    Acta Pol Pharm; 2010; 67(1):93-7. PubMed ID: 20210085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and evaluation of Ketoprofen sustained release matrix tablet using
    Kaleemullah M; Jiyauddin K; Thiban E; Rasha S; Al-Dhalli S; Budiasih S; Gamal OE; Fadli A; Eddy Y
    Saudi Pharm J; 2017 Jul; 25(5):770-779. PubMed ID: 28725150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrospun nanofibers in oral drug delivery.
    Ignatious F; Sun L; Lee CP; Baldoni J
    Pharm Res; 2010 Apr; 27(4):576-88. PubMed ID: 20143253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fast Dissolution Electrospun Medicated Nanofibers for Effective Delivery of Poorly Water-Soluble Drug.
    Aidana Y; Wang Y; Li J; Chang S; Wang K; Yu DG
    Curr Drug Deliv; 2022; 19(4):422-435. PubMed ID: 33588728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation development and in vitro evaluation of theophylline microcapsules.
    Ahmad M; Akhtar N; Murtaza G; Hussain SW
    Pak J Pharm Sci; 2012 Jan; 25(1):15-9. PubMed ID: 22186304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuro-fuzzy modeling of ibuprofen-sustained release from tablets based on different cellulose derivatives.
    Rebouh S; Lefnaoui S; Bouhedda M; Yahoum MM; Hanini S
    Drug Deliv Transl Res; 2019 Feb; 9(1):162-177. PubMed ID: 30341764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation and in-vitro evaluation of directly compressed controlled release matrices of Losartan Potassium using Ethocel Grade 100 as rate retarding agent.
    Khan KA; Khan GM; Zeeshan Danish M; Akhlaq ; Khan H; Rehman F; Mehsud S
    Int J Pharm; 2015 Dec; 496(2):759-65. PubMed ID: 26545310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.